New Drugs For Hiv

Here's a taste of what TheBody.com has to offer on this topic:

Articles

News on HIV Drug Resistance in New Antiretrovirals From the XVI International HIV Drug Resistance Workshop

Doug Richman provided a comprehensive recap on HIV resistance from the annual HIV resistance conference, held this year in June in Barbados. 1 His focus was on four major areas: resistance associated with the new non-nucleoside reverse... Read more »

U.S. Centers for Disease Control and Prevention

New Mexico: Health Department Offers New HIV Drugs to Patients

The New Mexico Department of Health recently announced it has added three new drugs to the states HIV/AIDS Medications Program. Each of the drugs is an HIV treatment approved by the Food and Drug Administration within the last six months, said... Read more »

New Protein Discovery Could Lead to New HIV Drugs

A team of researchers at the Johns Hopkins Bloomberg School of Public Health recently discovered a new protein that enables HIV to destroy human cells. The discovery provides scientists with an important look into the complex interactions between... Read more »

Ask the Experts

How good is this new hiv drug ???

Hi Dr Keith, how good is this new hiv drug ????thank you for your timeRossPanacos Pharmaceuticals announced yesterday that it has sold its first-in-class HIV maturation inhibitor bevirimat to Myriad Genetics, a biotechnology company that is also...

Response from Keith Henry, M.D.

University of Minnesota, School of Medicine

Bevirimat has shown moderate activity for the treatment of HIV infection including for virus which is resistant to the current HIV meds. Development is still early. For most HIV practices in US the currently HIV medications are usually working... Read more »

new hiv drug

Hi.. How many drug for hiv in 2003, Will they be more drug for hiv 2004... Thank you very much...

Response from Gerald Pierone, M.D.

AIDS Research and Treatment Center of the Treasure Coast

So far in 2003 we have had 3 approvals in the United States. T20, or enfuvirtide, or Fuzeon is an injectable medication for drug-resistant HIV. FTC, or emtricitabine, or Emtriva was just approved. This nucleoside reverse transcriptase inhibitor is... Read more »

New HIV Drug

Does anyone know when Sustiva/Viread/Emtriva will all be in one pill?...

Response from Benjamin Young, M.D., Ph.D.

Rocky Mountain CARES

Thanks for your question.I don't think that anyone knows exactly when or if this will happen, but there is considerable interest both within the pharmaceutical industry and the treatment community, alike.If everything goes smoothly, we could... Read more »

Can my group medical insurance refuse to cover the new HIV drugs Ineed?

...

Response from Nancy Breuer

WorkPositive, Inc.

Yes. If the drugs are considered "experimental or investigational,"the insurance company can deny coverage. This is usually defined as adrug not yet recognized throughout the medical profession in the U.S. assafe and effective for the... Read more »

Go to Ask the Experts »

Connect With Others

New Virus Leads Drugs to HIV-Infected Cells

Posted by new2this2010

This is great news.

http://www.dailytech.com/New+Virus+Leads+Drugs+to+HIVInfected+Cells/article22391.htm#cmt706319 Read more »

New York draws fire over case of drug-resistantHIV

Posted by Anonymous

Nature 433, 788 (24 February 2005)

New York draws fire over case of drug-resistant HIV

ERIKA CHECK

Rare, aggressive form of AIDS used to publicize dangers of unprotected
sex.

[WASHINGTON] A decision by New York health officials to announce the
detection... Read more »

new drugs overview (by a rookie), and comments

Posted by Anonymous

Many of you are much sharper about emerging hiv medications than I am...

Is this is good overview of some of the good emerging options??

I see two exciting classes of drugs. By this I mean they seem to show good efficacy in diminishing the viral load... Read more »

OLD DRUG, NEW INFORMATION: SF Trial of Peptide T

Posted by Anonymous

OLD DRUG, NEW INFORMATION:
Recruitment to Open for Peptide T Anti-Viral Trial

(Contact Diane Cenko, HIVCARE Client Outreach Coordinator, 415-353-6215 or 6259)

San Francisco, Calif. - February, 2001 -- A phase II study of Peptide T to evaluate its... Read more »

Connect on Our Bulletin Boards »

Tools

My Health Tracker

Assess Your Risk for HIV

Find Local HIV/AIDS Services

Resource Centers

Guides for People With HIV

View All of Our Guides >>